{
  "id": "COVID_General_Treatment.v0",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-03-12",
      "name": "Hongshuo Feng",
      "organisation": "Zhejiang University",
      "email": "842089819@qq.com"
    },
    "other_contributors": [
      "Tianhua Tang",
      "Shan Nan",
      "Yijie Wang"
    ],
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "General treatment options for COVID-19 patients.",
        "keywords": [
          "COVID-19"
        ],
        "use": "COVID-19 diagnosis and treatment decision support.",
        "copyright": "Zhejiang University"
      }
    },
    "other_details": {
      "references": "Chinese COVID-19 Diagnosis and Treatment Guideline (7th edition)"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-EVALUATION.problem_diagnosis.v1",
        "template_id": "openEHR-EHR-EVALUATION.problem_diagnosis.v1",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/items[at0073]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/items[at0005]"
          }
        }
      },
      "gt0005": {
        "id": "gt0005",
        "model_id": "openEHR-EHR-INSTRUCTION.service_request.v1",
        "template_id": "openEHR-EHR-INSTRUCTION.service_request.v1",
        "type": "OUTPUT",
        "elements": {
          "gt0006": {
            "id": "gt0006",
            "path": "/activities[at0001]/description[at0009]/items[at0121]"
          }
        }
      },
      "gt0007": {
        "id": "gt0007",
        "model_id": "openEHR-EHR-INSTRUCTION.medication_order.v2",
        "template_id": "openEHR-EHR-INSTRUCTION.medication_order.v2",
        "type": "OUTPUT",
        "elements": {
          "gt0008": {
            "id": "gt0008",
            "path": "/activities[at0001]/description[at0002]/items[at0070]"
          },
          "gt0016": {
            "id": "gt0016",
            "path": "/activities[at0001]/description[at0002]/items[at0107]"
          }
        }
      },
      "gt0009": {
        "id": "gt0009",
        "model_id": "openEHR-EHR-INSTRUCTION.care_plan_request.v0",
        "template_id": "openEHR-EHR-INSTRUCTION.care_plan_request.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0010": {
            "id": "gt0010",
            "path": "/activities[at0001]/description[at0004]/items[at0017]"
          }
        }
      }
    },
    "rules": {
      "gt0014": {
        "id": "gt0014",
        "priority": 1,
        "when": [
          "$gt0003|Diagnostic certainty|==local::at0092|Confirmed|",
          "(($gt0004|Severity|==local::at0086|Mild|)||($gt0004|Severity|==local::at0087|Normal |))||(($gt0004|Severity|==local::at0088|Severe|)||($gt0004|Severity|==local::at0089|Critical|))"
        ],
        "then": [
          "$gt0006|Service name|='(1)Based on patientâ€™s condition, monitor blood routine, urine routine, CRP, biochemical indicators (liver enzyme, myocardial enzyme, renal function, etc.) coagulation function, arterial blood gas analysis, chest imaging and so on. Where possible,perform Cytokine detection.(2) Provide effective oxygen therapy in a timely manner, including nasal cannula, Face-masked Oxygen Supply and transnasal high-flow oxygen therapy'",
          "$gt0008|Medication item|='Alpha-Interferon, Lopinavir/Ritonavir, Ribavirin, Chloroquine Phosphate, Arbidol'",
          "$gt0010|Plan name|='Stay in bed,enhance supportive treatment,guarantee enough heat;pay attention to water-electrolyte balance and maintain the stability of internal environment'",
          "$gt0016|Monitoring instruction|='(1)Pay attention to the adverse reactions related to Ritonavir/Lopinavir,such as diarrhea, nausea, vomi, liver damage and the interaction with other drugs. (2) It is not recommended to use 3 or more antiviral drugs at the same time, and the use of related drugs should be stopped when intolerable side effects occur.(3) Avoid blind or inappropriate use of antimicrobials, especially in combination with broad-spectrum antimicrobials'"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "COVID_General_Treatment",
            "description": "General treatment options for COVID-19 patients."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Diagnostic certainty",
            "description": "The level of confidence in the identification of the diagnosis."
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Severity",
            "description": "An assessment of the overall severity of the problem or diagnosis."
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Service name",
            "description": "The name of the single service or activity requested."
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Medication item",
            "description": "Name of the medication, vaccine or other therapeutic/prescribable item being ordered."
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Plan name",
            "description": "Identification of the care plan."
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Normal_treatment"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Monitoring instruction",
            "description": "An additional instruction which gives advice on recommended or required monitoring of the ordered item."
          }
        }
      }
    }
  }
}